Our results confirmed that naringin can regulate the NLRP3-caspase-1-IL-1β/IL-18 signaling pathway to affect the NLRP3 inflammasome, which can improve DKD by playing an anti-inflammatory role. This evidence concerns the gene IL18 and diabetic kidney disease.